[Form 4] NeueHealth, Inc. Insider Trading Activity
Jeffrey R. Immelt, a director of NeueHealth, Inc. (NEUE), reported a transaction dated
Jeffrey R. Immelt, un direttore di NeueHealth, Inc. (NEUE), ha riportato una transazione datata
Jeffrey R. Immelt, director de NeueHealth, Inc. (NEUE), informó una transacción con fecha
Jeffrey R. Immelt, NeueHealth, Inc. (NEUE)의 이사,
Jeffrey R. Immelt, administrateur de NeueHealth, Inc. (NEUE), a déclaré une transaction datée du
Jeffrey R. Immelt, ein Direktor von NeueHealth, Inc. (NEUE), berichtete eine Transaktion datiert auf
Jeffrey R. Immelt, مدير في NeueHealth, Inc. (NEUE), أبلغ عن صفقة بتاريخ
Jeffrey R. Immelt,是NeueHealth, Inc. (NEUE)的董事,报告的交易日期为
- Merger completed with issuer becoming a wholly-owned subsidiary of NH Holdings 2025, Inc. on
10/02/2025 - Rollover preserved economic interest by exchanging common and preferred shares for corresponding units on a one-for-one basis
- Reporting person now has 0 shares of direct common stock following the reported disposition
- Direct public reporting reduced, shifting ownership to an indirect holding vehicle controlled by private funds
Insights
Director moved from direct holdings to rolled-over private fund units after a merger.
The reported sale of 23,918 common shares and resulting 0 direct ownership reflects a common post-acquisition rollover where public stock is exchanged for private vehicle units. This shifts the reporting structure from direct public equity to indirect interest via NH Holdings 2025 SPV, L.P. which is controlled by funds affiliated with New Enterprise Associates, Inc.
This change reduces publicly reportable direct holdings while preserving economic exposure through the rollover units; monitor any future Section 16 filings for disclosures about the number or type of units held and any sale or distribution events within
The transaction stems from a closing of a merger and a contemporaneous rollover agreement.
The Form 4 ties the disposition to a Merger Agreement where the issuer merged into a Merger Sub and became a wholly-owned subsidiary of NH Holdings 2025, Inc. The Rollover Agreement converted public common and preferred shares into corresponding units on a one-for-one basis in the acquiring holding structure.
Key items to watch are any disclosures of the holding vehicle's capital structure and timing of liquidity events for rollover units, since those determine when former public holders might realize value; expect such details in follow-on filings or disclosure documents from the acquirer.
Jeffrey R. Immelt, un direttore di NeueHealth, Inc. (NEUE), ha riportato una transazione datata
Jeffrey R. Immelt, director de NeueHealth, Inc. (NEUE), informó una transacción con fecha
Jeffrey R. Immelt, NeueHealth, Inc. (NEUE)의 이사,
Jeffrey R. Immelt, administrateur de NeueHealth, Inc. (NEUE), a déclaré une transaction datée du
Jeffrey R. Immelt, ein Direktor von NeueHealth, Inc. (NEUE), berichtete eine Transaktion datiert auf